The Pharmaceutical Industry is faced with the challenge of implementing and managing innovation.
Pharmaceutical is the sector where Innovation has dramatic impact on the health and wellness of millions of people and the
bottom lines of companies that provide it. Companies have come to realise that in order to increase R&D productivity they need to dramatically improve their ability to harness knowledge and capability residing both within and beyond their organisational boundaries. For most of Pharmaceutical Companies innovation is the central element of their corporate mission.

COVID-19 global pandemic shows that the need of implementation of digital advanced technologies, such as Big Data
Analytics, Artificial Intelligence and other digital tools, is vital for the industry to thrive and be closer to the needs of patients.
Join our First Class Event and get the latest Innovative Insights from leading Pharmaceutical and Biotechnology Companies.

Dr. STEFAN PLATZ

Senior Vice President, Clinical Pharmacology & Safety Sciences

AstraZeneca

FREDERIC BONFILS

Corporate Alliance
Management Director

Pierre Fabre

Dr. WILLIAM MAIER

Vice President, Rare Disease,
Drug Development Sciences
ICON plc

CONFERENCE TOPICS

DAY ONE

How does pharma deal with building new innovative areas like advanced therapies (cell and gene)
Transforming Clinical Research Through Data, Analytics and Technology
Digital Twins from Discovery to Manufacturing: a Critical Investment Analysis
Impact of Omics Platforms and AI on Safety Assessment
Towards a 2030 Vision of Process Chemistry
Challenges in R&D Alliance through its Life Cycle – Partnerships/Collaboration for Early Assets Can Encounter Setbacks and External & Internal Changes Along the Way
Best Practices and Success Stories in Alliance Management
How to Deal with Ever-Growing Number of Biotech and Life Sciences Start-Ups
Alliance Management Organizational Development
Building a Culture to Support Academic – Industry Collaborations in the Pharmaceutical Sector
The Beauty and the Beast - Developing and Implementing Innovation in Pharma R&D
Industry-Academia Collaborations – Challenges and Opportunities

DAY TWO

Breakthrough vs Incremental Innovation
Dare to Share and Dare to Do
Boosting Innovation in Boehringer Ingelheim
Impact of Omics Platforms and AI on Safety Assessment
Innovation in Rare Disease Drug Development
Science and Innovation delivered Simpler, Smarter and Sharper
Accessing Innovation through External Alliances
Open Innovation Partnerships: An Integral Part of Research and Development
Pushing the Boundaries of Science through Open Innovation
Use of Modeling for Acceleration of Vaccine Drug Product Development and Tech Transfer
Formulation and Process Innovations in the Drug Product Development of Biopharmaceuticals

WHO SHOULD ATTEND?

WHAT TO EXPECT

REASONS TO ATTEND

till the 7th of June

IF YOU WORK IN PHARMA & BIOTECH INDUSTRIES IN ANY CAPACITY:

OPEN INNOVATION
EXTERNAL COLLABORATION & INNOVATION
EXTERNAL NETWORKS & PARTNERSHIPS
CORPORATE BUSINESS DEVELOPMENT
R&D
EXTERNAL DRUG DISCOVERY
STRATEGIC ALLIANCE MANAGEMENT
STRATEGIC & PARTNERING
ALLIANCE SOURCING & MANAGEMENT
CORPORATE RESEARCH & NETWORKING
DRUG DISCOVERY
TECHNOLOGY SCOUTING & NEW TECHNOLOGY
SCIENTIFIC AFFAIRS

WARM AND PROFESSIONAL WELCOME
CUTTING-EDGE TOPICS
WOLRD EXPERTS, THOUGHT LEADERS AND GLOBAL LEADING COMPANIESS
SPEAKERS FROM BOTH SIDES OF ATLANTIC
CONFERENCE MOBILE APPLICATION
PUNCTUALITY AND ATTENTION TO DETAILS
ENGAGING NETWORKING OVER GREAT HORS D’OEUVRES AND DRINKS
PROFESSIONAL, YET FRIENDLY AND RELAXED CONFERENCE ENVIRONMENT
PERSPECTIVES FROM DIFFERENT STAKEHOLDERS OF PHARMACEUTICAL MARKET
INTERACTIVE PANEL SESSIONS WITH RELEVANT TOPICS TO ENGAGE EVERYONE IN THE ROOM
MORE FEATURES THAN EVER!

MEET THE WORLD’S MARKET-LEADING PHARMACEUTICAL & BIOTECH COMPANIES
FIND PRACTICAL SOLUTIONS FOR CHALLENGES YOUR ORGANIZATION IS FACING
A COLLABORATIVE PLATFORM TO SHARE KNOW-HOW AMONG MAJOR MARKET PLAYERS
LISTEN TO THE BEST-PRACTICE EXAMPLES AND THE LESSONS LEARNED FROM THE CASE STUDIES
GROW YOUR PROFESSIONAL NETWORK, AND DISCUSS POTENTIAL ALLIANCES WITH THE INDUSTRY PEERS
GAIN A COMPETITIVE ADVANTAGE IN A RAPIDLY CHANGING BUSINESS ENVIRONMENT
INFLUENCE AND HELP SHAPE FUTURE TRENDS IN THE SECTOR

“Indeed, it is the first time I attended to a purely dedicated external innovation conference. I found the duration as well as the number of participants appropriate allowing to have fruitful exchanges. The quality of the presentations was very good and diversified which allows to maintain a good level of attention over these 2 days.”

— Associate VP, Head of Sanofi R&D Alliance
Management & Partnerships

Sanofi